Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Online First
Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
other Versions
You are currently viewing an
earlier version
of this article (February 06, 2020).
View the most recent version of this article
PDF
Original article
Role of front-line bevacizumab in advanced ovarian cancer: the OSCAR study
Online download statistics by month:
Online download statistics by month: November 2019 to April 2024
Abstract
Full
Pdf
Nov 2019
61
62
13
Dec 2019
239
225
132
Jan 2020
238
236
86
Feb 2020
489
485
96
Mar 2020
256
252
104
Apr 2020
450
443
92
May 2020
234
231
68
Jun 2020
188
181
47
Jul 2020
142
138
25
Aug 2020
117
112
30
Sep 2020
173
170
35
Oct 2020
143
141
40
Nov 2020
162
159
44
Dec 2020
108
104
41
Jan 2021
147
142
46
Feb 2021
83
81
23
Mar 2021
101
97
29
Apr 2021
114
113
31
May 2021
77
76
26
Jun 2021
98
97
27
Jul 2021
82
82
16
Aug 2021
66
65
17
Sep 2021
84
82
27
Oct 2021
72
72
36
Nov 2021
54
53
26
Dec 2021
40
39
15
Jan 2022
72
66
30
Feb 2022
87
87
26
Mar 2022
57
55
22
Apr 2022
78
77
17
May 2022
113
111
38
Jun 2022
144
148
39
Jul 2022
160
165
44
Aug 2022
148
152
43
Sep 2022
148
148
24
Oct 2022
140
129
26
Nov 2022
155
142
37
Dec 2022
140
137
20
Jan 2023
193
192
27
Feb 2023
170
171
33
Mar 2023
171
171
32
Apr 2023
183
183
34
May 2023
177
179
42
Jun 2023
156
154
29
Jul 2023
148
149
31
Aug 2023
168
168
40
Sep 2023
143
143
22
Oct 2023
130
129
23
Nov 2023
117
116
24
Dec 2023
158
139
40
Jan 2024
54
48
23
Feb 2024
114
108
31
Mar 2024
145
140
120
Apr 2024
86
84
32
Total
7773
7629
2121
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?